Point-of-Care Diagnostics-United States Market Status and Trend Report 2013-2023
Report Summary
Point-of-Care Diagnostics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Point-of-Care Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Point-of-Care Diagnostics in United States, with company and product introduction, position in the Point-of-Care Diagnostics market
Market status and development trend of Point-of-Care Diagnostics by types and applications
Cost and profit status of Point-of-Care Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the United States Point-of-Care Diagnostics market as:
United States Point-of-Care Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Point-of-Care Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Glucose Monitoring Kits
Infectious Diseases Testing Kits
Cardiometabolic Monitoring Kits
Coagulation Monitoring Kits
Hematology Testing Kits
Urinalysis Testing Kits
Cholesterol Test Strips
Drugs-Of-Abuse Testing Kits
Tumor/Cancer Markers
Other
United States Point-of-Care Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Home
Hospitals
Ambulatory Care
United States Point-of-Care Diagnostics Market: Players Segment Analysis (Company and Product introduction, Point-of-Care Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Abaxis
Alere
Bayer
Danaher Corporation
Becton Dickinson
Johnson & Johnson
Nipro
Roche Diagnostics
Siemens Healthcare
Samsung Medison
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Point-of-Care Diagnostics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Point-of-Care Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Point-of-Care Diagnostics in United States, with company and product introduction, position in the Point-of-Care Diagnostics market
Market status and development trend of Point-of-Care Diagnostics by types and applications
Cost and profit status of Point-of-Care Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the United States Point-of-Care Diagnostics market as:
United States Point-of-Care Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Point-of-Care Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Glucose Monitoring Kits
Infectious Diseases Testing Kits
Cardiometabolic Monitoring Kits
Coagulation Monitoring Kits
Hematology Testing Kits
Urinalysis Testing Kits
Cholesterol Test Strips
Drugs-Of-Abuse Testing Kits
Tumor/Cancer Markers
Other
United States Point-of-Care Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Home
Hospitals
Ambulatory Care
United States Point-of-Care Diagnostics Market: Players Segment Analysis (Company and Product introduction, Point-of-Care Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Abaxis
Alere
Bayer
Danaher Corporation
Becton Dickinson
Johnson & Johnson
Nipro
Roche Diagnostics
Siemens Healthcare
Samsung Medison
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF POINT-OF-CARE DIAGNOSTICS
1.1 Definition of Point-of-Care Diagnostics in This Report
1.2 Commercial Types of Point-of-Care Diagnostics
1.2.1 Glucose Monitoring Kits
1.2.2 Infectious Diseases Testing Kits
1.2.3 Cardiometabolic Monitoring Kits
1.2.4 Coagulation Monitoring Kits
1.2.5 Hematology Testing Kits
1.2.6 Urinalysis Testing Kits
1.2.7 Cholesterol Test Strips
1.2.8 Drugs-Of-Abuse Testing Kits
1.2.9 Tumor/Cancer Markers
1.2.10 Other
1.3 Downstream Application of Point-of-Care Diagnostics
1.3.1 Home
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.4 Development History of Point-of-Care Diagnostics
1.5 Market Status and Trend of Point-of-Care Diagnostics 2013-2023
1.5.1 United States Point-of-Care Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Point-of-Care Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Point-of-Care Diagnostics in United States 2013-2017
2.2 Consumption Market of Point-of-Care Diagnostics in United States by Regions
2.2.1 Consumption Volume of Point-of-Care Diagnostics in United States by Regions
2.2.2 Revenue of Point-of-Care Diagnostics in United States by Regions
2.3 Market Analysis of Point-of-Care Diagnostics in United States by Regions
2.3.1 Market Analysis of Point-of-Care Diagnostics in New England 2013-2017
2.3.2 Market Analysis of Point-of-Care Diagnostics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Point-of-Care Diagnostics in The Midwest 2013-2017
2.3.4 Market Analysis of Point-of-Care Diagnostics in The West 2013-2017
2.3.5 Market Analysis of Point-of-Care Diagnostics in The South 2013-2017
2.3.6 Market Analysis of Point-of-Care Diagnostics in Southwest 2013-2017
2.4 Market Development Forecast of Point-of-Care Diagnostics in United States 2018-2023
2.4.1 Market Development Forecast of Point-of-Care Diagnostics in United States 2018-2023
2.4.2 Market Development Forecast of Point-of-Care Diagnostics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Point-of-Care Diagnostics in United States by Types
3.1.2 Revenue of Point-of-Care Diagnostics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Point-of-Care Diagnostics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Point-of-Care Diagnostics in United States by Downstream Industry
4.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in New England
4.2.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The West
4.2.5 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The South
4.2.6 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Southwest
4.3 Market Forecast of Point-of-Care Diagnostics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
5.1 United States Economy Situation and Trend Overview
5.2 Point-of-Care Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 POINT-OF-CARE DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Point-of-Care Diagnostics in United States by Major Players
6.2 Revenue of Point-of-Care Diagnostics in United States by Major Players
6.3 Basic Information of Point-of-Care Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Point-of-Care Diagnostics Major Players
6.3.2 Employees and Revenue Level of Point-of-Care Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 POINT-OF-CARE DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Point-of-Care Diagnostics Product
7.1.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Abaxis
7.2.1 Company profile
7.2.2 Representative Point-of-Care Diagnostics Product
7.2.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis
7.3 Alere
7.3.1 Company profile
7.3.2 Representative Point-of-Care Diagnostics Product
7.3.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Alere
7.4 Bayer
7.4.1 Company profile
7.4.2 Representative Point-of-Care Diagnostics Product
7.4.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Bayer
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative Point-of-Care Diagnostics Product
7.5.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Becton Dickinson
7.6.1 Company profile
7.6.2 Representative Point-of-Care Diagnostics Product
7.6.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.7 Johnson & Johnson
7.7.1 Company profile
7.7.2 Representative Point-of-Care Diagnostics Product
7.7.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.8 Nipro
7.8.1 Company profile
7.8.2 Representative Point-of-Care Diagnostics Product
7.8.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Nipro
7.9 Roche Diagnostics
7.9.1 Company profile
7.9.2 Representative Point-of-Care Diagnostics Product
7.9.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.10 Siemens Healthcare
7.10.1 Company profile
7.10.2 Representative Point-of-Care Diagnostics Product
7.10.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.11 Samsung Medison
7.11.1 Company profile
7.11.2 Representative Point-of-Care Diagnostics Product
7.11.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Samsung Medison
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
8.1 Industry Chain of Point-of-Care Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
9.1 Cost Structure Analysis of Point-of-Care Diagnostics
9.2 Raw Materials Cost Analysis of Point-of-Care Diagnostics
9.3 Labor Cost Analysis of Point-of-Care Diagnostics
9.4 Manufacturing Expenses Analysis of Point-of-Care Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Point-of-Care Diagnostics in This Report
1.2 Commercial Types of Point-of-Care Diagnostics
1.2.1 Glucose Monitoring Kits
1.2.2 Infectious Diseases Testing Kits
1.2.3 Cardiometabolic Monitoring Kits
1.2.4 Coagulation Monitoring Kits
1.2.5 Hematology Testing Kits
1.2.6 Urinalysis Testing Kits
1.2.7 Cholesterol Test Strips
1.2.8 Drugs-Of-Abuse Testing Kits
1.2.9 Tumor/Cancer Markers
1.2.10 Other
1.3 Downstream Application of Point-of-Care Diagnostics
1.3.1 Home
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.4 Development History of Point-of-Care Diagnostics
1.5 Market Status and Trend of Point-of-Care Diagnostics 2013-2023
1.5.1 United States Point-of-Care Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Point-of-Care Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Point-of-Care Diagnostics in United States 2013-2017
2.2 Consumption Market of Point-of-Care Diagnostics in United States by Regions
2.2.1 Consumption Volume of Point-of-Care Diagnostics in United States by Regions
2.2.2 Revenue of Point-of-Care Diagnostics in United States by Regions
2.3 Market Analysis of Point-of-Care Diagnostics in United States by Regions
2.3.1 Market Analysis of Point-of-Care Diagnostics in New England 2013-2017
2.3.2 Market Analysis of Point-of-Care Diagnostics in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Point-of-Care Diagnostics in The Midwest 2013-2017
2.3.4 Market Analysis of Point-of-Care Diagnostics in The West 2013-2017
2.3.5 Market Analysis of Point-of-Care Diagnostics in The South 2013-2017
2.3.6 Market Analysis of Point-of-Care Diagnostics in Southwest 2013-2017
2.4 Market Development Forecast of Point-of-Care Diagnostics in United States 2018-2023
2.4.1 Market Development Forecast of Point-of-Care Diagnostics in United States 2018-2023
2.4.2 Market Development Forecast of Point-of-Care Diagnostics by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Point-of-Care Diagnostics in United States by Types
3.1.2 Revenue of Point-of-Care Diagnostics in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Point-of-Care Diagnostics in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Point-of-Care Diagnostics in United States by Downstream Industry
4.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in New England
4.2.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The Midwest
4.2.4 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The West
4.2.5 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in The South
4.2.6 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Southwest
4.3 Market Forecast of Point-of-Care Diagnostics in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
5.1 United States Economy Situation and Trend Overview
5.2 Point-of-Care Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 POINT-OF-CARE DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Point-of-Care Diagnostics in United States by Major Players
6.2 Revenue of Point-of-Care Diagnostics in United States by Major Players
6.3 Basic Information of Point-of-Care Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Point-of-Care Diagnostics Major Players
6.3.2 Employees and Revenue Level of Point-of-Care Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 POINT-OF-CARE DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Point-of-Care Diagnostics Product
7.1.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Abaxis
7.2.1 Company profile
7.2.2 Representative Point-of-Care Diagnostics Product
7.2.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis
7.3 Alere
7.3.1 Company profile
7.3.2 Representative Point-of-Care Diagnostics Product
7.3.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Alere
7.4 Bayer
7.4.1 Company profile
7.4.2 Representative Point-of-Care Diagnostics Product
7.4.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Bayer
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative Point-of-Care Diagnostics Product
7.5.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Becton Dickinson
7.6.1 Company profile
7.6.2 Representative Point-of-Care Diagnostics Product
7.6.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.7 Johnson & Johnson
7.7.1 Company profile
7.7.2 Representative Point-of-Care Diagnostics Product
7.7.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.8 Nipro
7.8.1 Company profile
7.8.2 Representative Point-of-Care Diagnostics Product
7.8.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Nipro
7.9 Roche Diagnostics
7.9.1 Company profile
7.9.2 Representative Point-of-Care Diagnostics Product
7.9.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.10 Siemens Healthcare
7.10.1 Company profile
7.10.2 Representative Point-of-Care Diagnostics Product
7.10.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.11 Samsung Medison
7.11.1 Company profile
7.11.2 Representative Point-of-Care Diagnostics Product
7.11.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Samsung Medison
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
8.1 Industry Chain of Point-of-Care Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
9.1 Cost Structure Analysis of Point-of-Care Diagnostics
9.2 Raw Materials Cost Analysis of Point-of-Care Diagnostics
9.3 Labor Cost Analysis of Point-of-Care Diagnostics
9.4 Manufacturing Expenses Analysis of Point-of-Care Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
